GDF-15 Monoclonal Antibodies European Patent Application EP3590537A1
Summary
European Patent Application EP3590537A1 for monoclonal antibodies targeting Growth and Differentiation Factor 15 (GDF-15) was published by the European Patent Office on April 15, 2026. The applicant is Julius-Maximilians-Universität Würzburg (Germany), with inventors Wischhusen, Junker, Müller, and Saremba. The application is classified under A61K 39/395 and C07K 16/22 and designates all EU member states plus several additional European countries.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The European Patent Office published Application EP3590537A1 for monoclonal antibodies against Growth and Differentiation Factor 15 (GDF-15), classified under IPC codes A61K 39/395 and C07K 16/22. The application names Julius-Maximilians-Universität Würzburg as applicant and four named inventors. The designation covers all EU member states plus additional European contracting states.\n\nPharmaceutical and biotechnology companies developing GDF-15 targeted therapies should review the patent claims to assess freedom-to-operate implications. Research institutions and drug developers working in the GDF-15/oncology or metabolic disease space may need to evaluate whether their activities fall within the scope of the claimed antibodies.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15)
Publication EP3590537A1 Kind: A1 Apr 15, 2026
Applicants
Julius-Maximilians-Universität Würzburg
Inventors
Wischhusen, Prof. Dr. Jörg, Junker, Markus, Müller, Thomas, Saremba, Stefan
IPC Classifications
A61K 39/395 20060101AFI20191113BHEP C07K 16/22 20060101ALI20191113BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.